ブルーのスーツに水玉模様のネクタイを締めた男性が、明るい屋内のプロフェッショナルな雰囲気の中で微笑んでいる。

ジョーダン・J・バーグマン

パートナー

ジョーダン・J・バーグマン

パートナー

Jordan Bergmann is a tax specialist and corporate lawyer, advising clients on a diverse array of domestic matters. A significant part of Jordan’s practice involves advising clients on the tax aspects of mergers and acquisitions. Jordan navigates clients through the intricacies of M&A transactions, from complete company sales to creatively structured deals with retained equity for selling shareholders. He takes a lead role in negotiating equity rollover arrangements, ensuring both tax efficiency and the satisfaction of his clients with all non-tax aspects involved.

One of Jordan’s areas of focus is also counseling clients on the effects of the “Golden Parachute” rules found in Section 280G of the Code. He guides clients through complex calculations and the shareholder vote process, making certain they understand and comply with the requirements.

Aside from his M&A Practice, Jordan’s experience extends to a wide range of tax and corporate considerations for privately held businesses. He assists clients in selecting the optimal entity structure for their ventures, designing equity compensation incentives tailored to partnerships, and structuring tax aspects of new investments. Jordan also works extensively with the Qualified Small Business Stock exclusion under Code Section 1202, providing his clients with insights into its many intricacies.

代表的な経験

  • Facilitated the acquisition of Vive Organic, Inc., a brand of immunity-supporting booster shots created by holistic medical professionals, by Suja Life, LLC, a portfolio company of Paine Schwartz Partners.
  • Negotiated the growth capital partnership for A1 Garage Door Service Holdings, Inc. (A1), a prominent player in the direct-to-consumer residential repair and replacement garage door services industry. The strategic partnership was formed with an affiliated investment group spearheaded by Cortec Group Fund VII, L.P., an investment portfolio managed by Cortec Group.
  • Successfully closed a comprehensive multilevel financing initiative for a multinational company, enabling the establishment and operation of oncology centers in India.
  • Represented a veteran-owned distillery in securing a pivotal investment from a major wine and spirits distributor, positioning the distillery for enhanced growth and market expansion.
  • Provided counsel to nVent Electric plc concerning golden parachute matters pertaining to its landmark $1.1 billion acquisition of ECM Industries, LLC, ensuring compliance with regulatory requirements and optimal shareholder outcomes.

受賞歴

  • Best Lawyers: Ones to Watch recognition for:
    • Corporate Law (2022, 2024)
    • Employee Benefits Law (2022)
    • Tax Law (2022-2024)

プレゼンテーションと出版物

  • Co-author, “Tax Law” chapter in the Wisconsin State Bar’s Annual Survey of Wisconsin Law (2015 and 2016).
2025年11月5日 契約と勝利

フォーリー、ソレニス社への売却でNCHコーポレーションを代理

フォーリー&ラードナー法律事務所は、プラチナ・エクイティの投資先であるソレニス社への売却において、ミドルマーケットにおける水処理および産業ソリューションの品質リーダーであり、信頼できる現場専門家であるNCHコーポレーションの法律アドバイザーを務めた。
2025年7月10日 フォーリービューポイント

トランプ政権が「一大美法案」を可決

2025年7月4日、トランプ大統領はH.R.1-One Big Beautiful Bill Act(OBBBA)と呼ばれる-に署名した。OBBBAは、...
2025年6月30日 ニュース

Jordan Bergmann on Fate of 45X Advanced Manufacturing Production Tax Credit

Foley & Lardner LLP partner Jordan Bergmann shared context on important tax incentives for battery manufacturers in Milwaukee Business Journal, offering insight into what their inclusion in the budget reconciliation bill under deliberation may mean for Wisconsin manufacturers.
2025年5月1日 取引と勝利

フォーリー、プライベート・エクイティ企業によるネクストーク社買収のリーガル・アドバイザーを務める

フォーリー&ラードナー法律事務所は、ろう者、難聴者、非英語圏コミュニティ向けコミュニケーション・ソリューションの業界リーダーであるNexTalk社のプライベート・エクイティ企業による買収を代理した。
2025年2月3日 プレスリリース

フォーリー、2025年の新パートナー・クラスを発表

フォーリー&ラードナー法律事務所は、2025年2月1日付で17名の弁護士をパートナーシップに昇格させることを発表いたします。
October 31, 2024 Deals and Wins

Foley Advises NorthGauge HealthCare in Partnership with Coker

Foley & Lardner LLP served as legal advisor to NorthGauge Healthcare, a national provider of medical review and advisory services, in the formation of its strategic partnership with Coker, a leading health care advisory firm.